Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Anesthesiology and Pain Medicine,Clinical Neurology,Neurology
Reference52 articles.
1. Nociception in cyclooxygenase isozyme-deficient mice.;Ballou;Proc Natl Acad Sci USA,2000
2. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis.;Beiche;Inflamm Res,1998
3. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.;Cannon;Arthritis Rheum,2000
4. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.;DeWitt;Am J Med,1993
5. Pharmacologic treatments for temporomandibular disorders.;Dionne;Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1997
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the gut microbiota’s effect on temporomandibular joint disorder: a two−sample Mendelian randomization analysis;Frontiers in Cellular and Infection Microbiology;2024-08-12
2. Diagnosis and Treatment of Temporomandibular Disorders;The Journal of The Korean Dental Association;2024-07-31
3. Conservative versus Invasive Approaches in Temporomandibular Disc Displacement: A Systematic Review of Randomized Controlled Clinical Trials;Dentistry Journal;2024-07-31
4. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis;BMC Oral Health;2024-01-13
5. Additional splint therapy has no superiority in myogenic temporomandibular disorders: A systematic review and meta-analysis of randomized controlled trials;Journal of Prosthodontic Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3